Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;27(4):747-759.
doi: 10.1007/s10120-024-01504-7. Epub 2024 May 25.

CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

Affiliations

CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

Cristina Herrera-Pariente et al. Gastric Cancer. 2024 Jul.

Abstract

Background: CDH1 and CTNNA1 remain as the main genes for hereditary gastric cancer. However, they only explain a small fraction of gastric cancer cases with suspected inherited basis. In this study, we aimed to identify new hereditary genes for early-onset gastric cancer patients (EOGC; < 50 years old).

Methods: After germline exome sequencing in 20 EOGC patients and replication of relevant findings by gene-panel sequencing in an independent cohort of 152 patients, CTNND1 stood out as an interesting candidate gene, since its protein product (p120ctn) directly interacts with E-cadherin. We proceeded with functional characterization by generating two knockout CTNND1 cellular models by gene editing and introducing the detected genetic variants using a lentiviral delivery system. We assessed β-catenin and E-cadherin levels, cell detachment, as well as E-cadherin localization and cell-to-cell interaction by spheroid modeling.

Results: Three CTNND1 germline variants [c.28_29delinsCT, p.(Ala10Leu); c.1105C > T, p.(Pro369Ser); c.1537A > G, p.(Asn513Asp)] were identified in our EOGC cohorts. Cells encoding CTNND1 variants displayed altered E-cadherin levels and intercellular interactions. In addition, the p.(Pro369Ser) variant, located in a key region in the E-cadherin/p120ctn binding domain, showed E-cadherin mislocalization.

Conclusions: Defects in CTNND1 could be involved in germline predisposition to gastric cancer by altering E-cadherin and, consequently, cell-to-cell interactions. In the present study, CTNND1 germline variants explained 2% (3/172) of the cases, although further studies in larger external cohorts are needed.

Keywords: Cell adhesion; Delta catenin; Early-onset disease; Genetic predisposition to disease; Stomach neoplasms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Functional characterization of the CTNND1-depleted NCI-N87 cell model by CRISPR/Cas9. a Quantification of relative protein levels of E-cadherin and β-catenin by Western blot. GAPDH was used as internal control. Representative blot of n = 4 (mean ± SD; Welch’s t-test, ∗∗∗P < 0.001). b Immunofluorescent staining of spheroids (NCI-N87 and NCI KO10) using p120ctn and E-cadherin antibodies. CRISPR-mediated CTNND1 editing resulted in p120ctn complete depletion and reduced E-cadherin expression. Wide-field microscopy images (left panel) were captured using a 10 × objective (Scale bar = 100 µm). A small area is shown at higher magnification (right panel, 63 × oil objective, scale bar = 20 µm). c Representative pictures of NCI-N87 and NCI KO10 spheroids. Scale bar = 200 µm. Circularity, compactness and roundness index decreased after p120ctn deletion. Spheroids were generated at least in quintuplicate and the experiment was repeated 3 times (n = 3; mean ± SD; Welch’s t-test, ∗∗∗P < 0.001). d Detachment time-course assay. Data represent the percentage of remaining attached cells after being treated with trypsin at different timepoints (n = 9, mean ± SD; Welch’s t-test, P < 0.05)
Fig. 2
Fig. 2
CTNND1 variants compromise E-cadherin levels and its membrane localization. a Quantification of relative protein levels of E-cadherin and β-catenin by Western blot. GAPDH was used as internal control. Representative blot of n = 4 (mean ± SD; analysis of variance with LSD post hoc test, *P < 0.05). b Immunofluorescent staining of spheroids expressing p120ctn variants. The vesicular internalization pattern of E-cadherin can be detected in cells expressing CTNND1 p.(Pro369Ser). Wide-field microscopy images (left panel) were captured using a 10 × objective (Scale bar = 100 µm). A small area is shown at higher magnification (right panel, 63 × oil objective, scale bar = 20 µm). Protein annotation is in its short form
Fig. 3
Fig. 3
CTNND1 variants affect cell-to-cell interactions. a Representative pictures of spheroids expressing each CTNND1 variant or its wild-type counterpart. Circularity, compactness and roundness index are represented. Spheroids were generated at least in quintuplicate and the experiment was repeated 3 times (n = 3; mean ± SD; analysis of variance with LSD post hoc test, P < 0.05). b Detachment assay. Data represent the percentage of remaining attached cells after being treated with trypsin for 8 min (n = 9, mean ± SD; analysis of variance with LSD post hoc test, P < 0.05). Protein annotation is in its short form
Fig. 4
Fig. 4
Schematic representation of p120ctn variants within the functional domains of the protein. ARM Armadillo domain
Fig. 5
Fig. 5
Schematic representation of the proposed molecular mechanism of pathogenicity for CTNND1 germline variants. CTNND1 germline variants affect p120ctn-E-cadherin binding and compromise cell-to-cell interactions, which could lead to GC predisposition

References

    1. Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3:874–883. doi: 10.1016/S2468-1253(18)30237-1. - DOI - PMC - PubMed
    1. Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol. 2015;1:23–32. doi: 10.1001/jamaoncol.2014.168. - DOI - PubMed
    1. Clark DF, Michalski ST, Tondon R, Nehoray B, Ebrahimzadeh J, Hughes SK, et al. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer. Genet Med. 2020;22:840–846. doi: 10.1038/s41436-020-0753-1. - DOI - PMC - PubMed
    1. Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet. 2016;98:830–842. doi: 10.1016/j.ajhg.2016.03.001. - DOI - PMC - PubMed
    1. Milne AN, Offerhaus GJA. Early-onset gastric cancer: Learning lessons from the young. World J Gastrointest Oncol. 2010;2:59–64. doi: 10.4251/wjgo.v2.i2.59. - DOI - PMC - PubMed